Yangao, Jean T.
HRN: 21-28-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/26/2022
05/02/2022
IV
500 Mg
Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes